Interactive Strength Inc. (Nasdaq: TRNR) Receives Letter
The letter Confirms Compliance as a Result of the Company’s Successful Execution of Its Compliance Plan Stockholders’ Equity Was Increased Through the Acquisition...
Viper Energy Announces Pricing of Secondary Common Stock
MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the pricing of an underwritten public...
HSBC Bank PLC: Pre Stabilisation Notice
LONDON, March 05, 2024 (GLOBE NEWSWIRE) -- WPP Finance 2013 Pre Stabilisation Notice ...
Extension of the Offer Period
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW...
Brains Bioceutical Corp, the Global Leader in Natural
Vancouver, Canada & London, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), Brains Bio,...
Ultra Lithium Granted Voluntary Management Cease Trade
VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) -- Ultra Lithium Inc. (TSXV: ULT OTCQB: ULTXF Frankfurt: QFB) (“Ultra Lithium” or the...
Olema Oncology Reports Inducement Grants Under Nasdaq
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused...
Completion of Placement to Zijin Mining
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) is pleased to announce that the...
Scilex Holding Company Announces that the Official
PALO ALTO, Calif., March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring,...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare...
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq
REDWOOD CITY, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused...
G1 Therapeutics Announces Inducement Grants Under Nasdaq
RESEARCH TRIANGLE PARK, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the...
